News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
US FDA Panel Rejects Forest Laboratories, Inc., Nycomed Lung Drug
April 8, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Forest Laboratories Inc suffered a setback on Wednesday as a U.S. advisory panel voted against recommending approval of an experimental drug to treat a common and deadly lung disorder.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Huntington’s disease
FDA Minutes Confirm Challenging Path Ahead for UniQure’s Huntington’s Gene Therapy
December 4, 2025
·
2 min read
·
Heather McKenzie
Vaccines
Former CDC, FDA Chiefs Decry Vaccine Policy Changes as ACIP Meeting Begins
December 4, 2025
·
2 min read
·
Dan Samorodnitsky
Policy
FDA Eyes Higher User Fees for Companies Holding Phase I Studies Abroad
December 4, 2025
·
2 min read
·
Tristan Manalac
Vaccines
FDA To Provide Further Data on 10 Alleged Pediatric Deaths Linked to COVID-19 Vaccines By End of Month
December 4, 2025
·
2 min read
·
Tristan Manalac